Infinity Pharmaceuticals, Inc. (INFIQ) Financials
Stock symbol INFIQ is outdated, potentially delisted? Maybe it is available on other exchange?
INFIQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2023 | 21.2 million | 58.6 million |
| March 31, 2023 | 30.0 million | 58.3 million |
| Dec. 31, 2022 | 42.2 million | 61.2 million |
| Sept. 30, 2022 | 51.6 million | 62.5 million |
INFIQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2023 | -8.0 million | 856000 |
| March 31, 2023 | -12.6 million | 1.8 million |
| Dec. 31, 2022 | -8.9 million | 1.0 million |
| Sept. 30, 2022 | -9.4 million | ? |
INFIQ Net Income
No data available :(
INFIQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2023 | 17.7 million | - | 633000 |
| March 31, 2023 | 25.7 million | - | 777000 |
| Dec. 31, 2022 | 38.3 million | 47.2 million | 917000 |
| Sept. 30, 2022 | 47.2 million | 47.8 million | 1.1 million |
INFIQ Shares Outstanding
INFIQ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2023 | - | 6.6 million | 3.8 million | - |
| March 31, 2023 | - | 5.9 million | 5.9 million | - |
| Dec. 31, 2022 | - | 7.0 million | 2.8 million | - |
| Sept. 30, 2022 | - | 7.6 million | 3.5 million | - |
INFIQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2023 | 583000 | 352000 |
| March 31, 2023 | 731000 | 441000 |
| Dec. 31, 2022 | 543000 | 327000 |
| Sept. 30, 2022 | 712000 | 540000 |
INFIQ
Price: $0
52 week price:
Earnings Per Share: -4.60 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9076